Stay updated on Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial page.

Latest updates to the Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial page
- Check2 days agoChange DetectedThe page now shows revision v3.6.3 instead of v3.6.2, indicating a small metadata update to the page.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a refreshed version of the page's assets or content. This reflects the current published revision.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew user guidance and navigation items have been added, including How to Read a Study Record, Common Questions, How to Join a Study, and a recruitment status note stating No longer looking for participants. The page also updates header naming and versioning (Intervention / Treatment removed and replaced with Intervention/Treatment; Revision: v3.5.5 updated to Revision: v3.6.0).SummaryDifference0.4%

- Check31 days agoChange DetectedThe revision label on the page updated from Revision: v3.5.4 to Revision: v3.5.5. This signals a newer build rather than a modification to content or features.SummaryDifference0.0%

- Check45 days agoChange DetectedMelanoma and a related topics link (MedlinePlus Genetics) were removed from the page's metadata/navigation. This change reduces the visible disease tagging and access to the related genetics resource on the page, within the context of the trial record.SummaryDifference0.1%

- Check52 days agoChange DetectedMelanoma is added as a topic tag, and a related topics entry for MedlinePlus Genetics is introduced. The page revision is updated from v3.5.3 to v3.5.4.SummaryDifference0.2%

Stay in the know with updates to Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial page.